Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
Source:http://linkedlifedata.com/resource/pubmed/id/15668467
J. Clin. Oncol.
2005
Mar
20
23
9
1984-92
